David Platt - 21 Aug 2023 Form 4 Insider Report for BIOXYTRAN, INC (BIXT)

Role
CEO, Director, 10%+ Owner
Signature
David Platt
Issuer symbol
BIXT
Transactions as of
21 Aug 2023
Net transactions value
+$160,000
Form type
4
Filing time
24 Aug 2023, 15:15:48 UTC
Previous filing
17 May 2023
Next filing
15 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIXT common stock Gift $160,000 +500,000 +5.1% $0.3200 10,269,393 21 Aug 2023 by NDPD Pharma, Inc. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The total holdings in BIXT by NDPD Pharma, Inc., partly owned by officers of BIXT, are consolidated under indirect ownership in Davis Platt's filing.